166 related articles for article (PubMed ID: 6356119)
1. The treatment of irritable bowel syndrome. Two doses of mebeverine compared.
Prout BJ
Practitioner; 1983 Oct; 227(1384):1607-8. PubMed ID: 6356119
[No Abstract] [Full Text] [Related]
2. [Controlled clinical study of the action of mebeverine hydrochloride in the treatment of irritable colon].
Secco GB; Di Somma C; Arnulfo G; Ricci C
Minerva Med; 1983 Mar; 74(13):699-702. PubMed ID: 6339996
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two different formulations of mebeverine hydrochloride in irritable bowel syndrome.
Gilbody JS; Fletcher CP; Hughes IW; Kidman SP
Int J Clin Pract; 2000 Sep; 54(7):461-4. PubMed ID: 11070572
[TBL] [Abstract][Full Text] [Related]
4. A general practice study to compare alverine citrate with mebeverine hydrochloride in the treatment of irritable bowel syndrome.
Tudor GJ
Br J Clin Pract; 1986 Jul; 40(7):276-8. PubMed ID: 3527247
[No Abstract] [Full Text] [Related]
5. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
Chapman ND; Grillage MG; Mazumder R; Atkinson SN
Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997
[TBL] [Abstract][Full Text] [Related]
6. Mebeverine in patients with the irritable colon syndrome: double blind study.
Tasman-Jones C
N Z Med J; 1973 Apr; 77(491):232-5. PubMed ID: 4581721
[No Abstract] [Full Text] [Related]
7. A double-blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome.
Van Outryve M; Mayeur S; Meeus MA; Rosillon D; Hendrickx B; Ceuppens M
J Clin Pharm Ther; 1995 Oct; 20(5):277-82. PubMed ID: 8576295
[TBL] [Abstract][Full Text] [Related]
8. [The irritable colon syndrome. New therapeutic possibilities in the treatment of a frequent syndrome].
Eisenburg J; Kruis W; Schüssler P; Weinzierl M
Fortschr Med; 1978 Nov; 96(41):2064-70. PubMed ID: 700592
[TBL] [Abstract][Full Text] [Related]
9. [Anticholinergic and benzodiazepine drugs in the therapy of functional colonic diseases].
Del Vecchio-Blanco C; Stroffolini T
Minerva Dietol Gastroenterol; 1981; 27(4):593-8. PubMed ID: 7038544
[No Abstract] [Full Text] [Related]
10. Double-blind study of a new antimuscarinic, cimetropium bromide, in patients with irritable bowel syndrome.
Ferrari A; Cavallero M; Spandre M; Gemme C; Rossini FP; Imbimbo BP
Clin Ther; 1986; 8(3):320-8. PubMed ID: 3521859
[TBL] [Abstract][Full Text] [Related]
11. Double blind trial of trimebutine in the irritable bowel syndrome.
Fielding JF
Ir Med J; 1980 Oct; 73(10):377-9. PubMed ID: 7000730
[No Abstract] [Full Text] [Related]
12. [Treatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placebo].
Lech Y; Olesen KM; Hey H; Rask-Pedersen E; Vilien M; Ostergaard O
Ugeskr Laeger; 1988 Oct; 150(40):2388-9. PubMed ID: 3061106
[No Abstract] [Full Text] [Related]
13. [The value of adding an antispasmodic musculotropic agent in the treatment of painful constipation in functional colopathies with bran. Double-blind study].
Delmont J
Med Chir Dig; 1981; 10(4):365-70. PubMed ID: 7029167
[No Abstract] [Full Text] [Related]
14. Double blind trial of ispaghula/poloxamer in the Irritable Bowel Syndrome.
Arthurs Y; Fielding JF
Ir Med J; 1983 May; 76(5):253. PubMed ID: 6307924
[No Abstract] [Full Text] [Related]
15. Evaluation of tricyclic compound (trimipramine) vis-a-vis placebo in irritable bowel syndrome. (Double blind randomised study).
Tripathi BM; Misra NP; Gupta AK
J Assoc Physicians India; 1983 Apr; 31(4):201-3. PubMed ID: 6358181
[No Abstract] [Full Text] [Related]
16. Mebeverine alters small bowel motility in irritable bowel syndrome.
Evans PR; Bak YT; Kellow JE
Aliment Pharmacol Ther; 1996 Oct; 10(5):787-93. PubMed ID: 8899088
[TBL] [Abstract][Full Text] [Related]
17. A randomised, double-blind study of mebeverine versus dicyclomine in the treatment of functional abdominal pain in young adults.
Grillage MG; Nankani JN; Atkinson SN; Prescott P
Br J Clin Pract; 1990 May; 44(5):176-9. PubMed ID: 2202405
[No Abstract] [Full Text] [Related]
18. Peppermint oil does not relieve the pain of irritable bowel syndrome.
Nash P; Gould SR; Bernardo DE
Br J Clin Pract; 1986 Jul; 40(7):292-3. PubMed ID: 3527248
[No Abstract] [Full Text] [Related]
19. Peppermint oil for the irritable bowel syndrome: a multicentre trial.
Dew MJ; Evans BK; Rhodes J
Br J Clin Pract; 1984; 38(11-12):394, 398. PubMed ID: 6397219
[No Abstract] [Full Text] [Related]
20. Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients.
Jones RH; Holtmann G; Rodrigo L; Ehsanullah RS; Crompton PM; Jacques LA; Mills JG
Aliment Pharmacol Ther; 1999 Nov; 13(11):1419-27. PubMed ID: 10571597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
